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Abstract
Introduction: The aim of this study was to determine whether counselling provided subsequent to HIV testing and referral
for care increases linkage to care among HIV-positive persons identified through home-based HIV counselling and testing
(HBHCT) in Masaka, Uganda.
Methods: The study was an open-label cluster-randomized trial. 28 rural communities were randomly allocated (1:1) to inter-
vention (HBHCT, referral and counselling at one and two months) or control (HBHCT and referral only). HIV-positive care-
na€ıve adults (≥18 years) were enrolled. To conceal participants’ HIV status, one HIV-negative person was recruited for every
three HIV-positive participants. Primary outcomes were linkage to care (clinic-verified registration for care) status at six
months, and time to linkage. Primary analyses were intention-to-treat using random effects logistic regression or Cox regres-
sion with shared frailty, as appropriate.
Results: Three hundred and two(intervention, n = 149; control, n = 153) HIV-positive participants were enrolled. Except for
travel time to the nearest HIV clinic, baseline participant characteristics were generally balanced between trial arms. Retention
was similar across trial arms (92% overall). One hundred and twenty-seven (42.1%) participants linked to care: 76 (51.0%) in
the intervention arm versus 51 (33.3%) in the control arm [odds ratio = 2.18, 95% confidence interval (CI) = 1.26–3.78;
p = 0.008)]. There was evidence of interaction between trial arm and follow-up time (p = 0.009). The probability of linkage to
care, did not differ between arms in the first two months of follow-up, but was subsequently higher in the intervention arm
versus the control arm [hazard ratio = 4.87, 95% CI = 1.79–13.27, p = 0.002].
Conclusions: Counselling substantially increases linkage to care among HIV-positive adults identified through HBHCT and
may enhance efforts to increase antiretroviral therapy coverage in sub-Saharan Africa.
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1 | INTRODUCTION
Home-based HIV counselling and testing (HBHCT) is highly
acceptable [1–3] and has the potential to substantially
increase knowledge of HIV status in sub-Saharan Africa (SSA)
[4]. However, linkage to care following HBHCT is often inade-
quate. In the absence of interventions to facilitate linkage, less
than one-third of HIV-positive persons identified through
HBHCT in SSA link to care [5].
In order for the populations targeted by HBHCT to benefit
from HIV prevention and care services, interventions that can
link them to these services need to be identified and utilized.
Results from observational studies suggest that counselling
provided after referral could increase linkage to care among
HIV-positive persons identified through HBHCT in SSA [6–
10]. A major limitation of observational studies, however, is
that it is difficult to account for the effects of confounding fac-
tors. Therefore, randomized trials are required to determine
the potential effects of counselling on linkage to care.
In this study, we evaluated the effectiveness of counselling
after HIV diagnosis and referral to care, compared to referral
to care only, on linkage to care among HIV-positive individu-
als identified through HBHCT in Masaka, Uganda. We used
a cluster-randomized design to reduce the risk of contamina-
tion between trial arms and increase acceptability of the
interventions.
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2 | METHODS
2.1 | Study design and participants
The study was an open-label cluster-randomized controlled
trial. A description of the methods has been previously
reported [11]. Briefly, 28 communities (clusters) were ran-
domly allocated (1:1) to intervention (HBHCT, referral and
counselling at one and two months) or control (HBHCT and
referral only). HBHCT was offered to all adults (≥18 years).
Newly and previously identified HIV-positive persons were eli-
gible to participate if they were able to consent, not previ-
ously or currently in care, available for follow-up, and not
participating in other health-related research. To reduce the
possibility of revealing participants’ HIV status to other com-
munity members, one HIV-negative adult was recruited for
every three HIV-positive participants.
2.2 | Study setting
The study area comprised three rural subcounties of Masaka,
a district in south-western Uganda. The subcounties have clin-
ics that offer free HIV care and antiretroviral therapy (ART).
Typically, patients newly presenting for care were issued a
clinic number and card (registration), underwent a clinical
examination and CD4 count testing (results were usually avail-
able after two to four weeks), started on cotrimoxazole pro-
phylaxis (CTXp), and if eligible, ART. At the time of the study,
the CD4 count threshold for ART eligibility in Uganda was
≤500 cells/mm3 [12].
2.3 | Intervention
2.3.1 | Development
The intervention was developed based on published evidence
indicating that psychosocial factors are common barriers of
linkage to HIV care in SSA [13–23], and that counselling can
reduce the effects of these barriers [17,24–28] and may
increase linkage [6,7,9].
2.3.2 | Content
Counselling sessions addressed the following generic points:
acceptance of HIV diagnosis, plans to seek care, fear or experi-
ence of stigma, importance of HIV status disclosure and avail-
ability of psychosocial support for linkage to care; and
information about available care services, antiretroviral drugs
and the rationale for early linkage to care. In addition, the ses-
sions were used to address personal issues, e.g. marital discord
arising after disclosure of HIV status. HIV-negative participants
in the intervention arm received HIV risk reduction counselling
and information on the importance of regular HCT.
2.3.3 | Staff training
Counsellors did not have medical training but were trained in
HCT and had experience in conducting community-based
HCT. Training on the intervention was conducted in the four
weeks prior to study initiation and consisted of: i) one group
seminar that comprised a didactic 30-min presentation and
60-min interactive session; ii) a single 30-min one-on-one ses-
sion with each of the counsellors that was conducted one to
two weeks after the seminar.
2.3.4 | Quality assurance
Counsellors were provided with a checklist of the counselling
content to refer to during the sessions. In addition, counsel-
lors took notes of the issues discussed in each session. The
study investigator reviewed these notes and discussed any
omissions with individual counsellors.
2.4 | Outcomes
Primary outcomes were linkage to care (clinic-verified regis-
tration for care), determined six months after HIV diagnosis,
and time to linkage. Secondary outcomes were time to clinic-
verified receipt of a CD4 count and ART initiation, and self-
reported adherence to CTXp. A further secondary outcome
was uptake of repeat HCT at the six month visit among HIV-
negative participants.
2.5 | Randomization
A cluster was defined as a village or a set of villages with at least
400 adults. Clusters were separated by a buffer zone of ≥1
non-participating villages to minimize the risk of contamination.
Clusters were randomly allocated to intervention and control
arms. Stratification and restricted randomization were used to
minimize between-cluster variation and achieve overall balance
between trial arms with regard to key variables [11]. Stratifica-
tion was defined by distance (≤10 or >10 km) from the district
capital, and by cluster make-up, i.e. whether the cluster was
composed of a single village or several villages. Restricted ran-
domization was then applied to achieve balance on the following
cluster-level variables: size (total number of adults); presence of
a trading centre; location along a major road; lakeshore location
and presence of an HIV clinic within 5 km.
2.6 | Procedures
2.6.1 | HCT
Following community mobilization, standard HCT (including
pre-test and post-test counselling) was provided to all adults in
each randomized community. Married/cohabiting individuals
had the option of receiving HCT as a couple. Blood obtained
by finger-prick was tested using HIV rapid test kits: Alere
Determine HIV-1/HIV-2 (Alere Medical, Japan) for screening,
Stat-Pak HIV 1/2 (Chembio Diagnostic systems, USA) for confir-
mation of positive results and Uni-Gold HIV 1/2 (Trinity Bio-
tech, Ireland) as tie-breaker. Post-test counselling included a
discussion of HIV risk reduction strategies, disclosure plans,
partner testing, care and support services and referral options.
2.6.2 | Enrolment
Eligible individuals received information about the study
including that their community could be in either of the trial
arms and invited to consent. After enrolment, individuals were
informed about which trial arm their community was allocated
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to. Participants completed a counsellor-administered question-
naire on socio-demographic characteristics and HCT history.
2.6.3 | Referral
HIV-positive participants received a referral form a copy of
which was retained in a centrally stored folder. Data recorded
on the form included the participant’s names, age, sex, study
number and address.
2.6.4 | Counselling sessions
These were conducted at participants’ homes one and two
months after HBHCT; each lasted approximately 45 min.
Counselling was conducted using a client-centred approach,
i.e. it was tailored to the participant’s needs and circumstances
[29]. Issues identified in the first session were followed up in
the second session (for 92% of the participants, both sessions
were conducted by the same counsellor). Counsellors worked
across clusters.
2.6.5 | Collection of outcome data
Six months after HBHCT, all participants were visited by a
counsellor (for 58% of the participants in the intervention
arm, this was the same counsellor who had conducted the
counselling sessions) to collect information on study outcomes.
To assess the potential of contamination between trial arms,
counsellors asked participants if they had discussed the study
with fellow participants from other villages.
For each participant who reported that they linked to care, a
field team member visited the clinic to verify whether the par-
ticipant had indeed been registered for care. Participants whose
records could not be found were re-interviewed to clarify
whether they had actually linked or not. Only participants
whose records were found were categorized as “linkers”. Partic-
ipants’ clinic records were checked to confirm CD4 count test-
ing and receipt of the results, and initiation of CTXp and ART.
Adherence to CTXp was measured by self-reported responses
to a question on missed doses. Participants who missed ≤5 of
30 doses in the past month were categorized as “adherers”.
2.6.6 | HIV-negative study component
Similar enrolment and follow-up counselling procedures were
applied to HIV-negative participants. Repeat HBHCT was
offered to participants in both arms at six months.
2.7 | Ethical considerations
The trial was approved by Uganda Virus Research Institute
Research Ethics Committee, the Uganda National Council for
Science and Technology, and the Ethics Committee of the Lon-
don School of Hygiene and Tropical Medicine. Written
informed consent was obtained from each participant. The
trial is registered at ClinicalTrials.gov (NCT02497456).
2.8 | Sample size
On the basis of findings from HBHCT studies in which only
referral was provided following HIV diagnosis [30–33] and
those in which counselling was provided after referral [6,7], we
assumed linkage of 35% in the control arm and that this would
increase to 60% in the intervention arm.We aimed to have 80%
power to detect this increase at a significance level of 5%. On
the basis of data from settings similar to Masaka [11], we
assumed that the between-cluster coefficient of variation (k) for
linkage in the absence of intervention was 0.25. Based on these
assumptions and an estimated harmonic mean of seven partici-
pants per cluster, 28 clusters would be needed. This sample size
would also provide >80% power to detect a hazard ratio of 1.7
for the effect of the intervention on time to linkage [34].
2.9 | Analysis
All analyses were pre-specified. The primary analyses were
intention-to-treat and based on individual-level data, since
there was a sufficient number of clusters per arm and the
cluster size varied considerably [35]. Random effects logistic
regression and Cox regression with shared frailty were used
to estimate the effect of the intervention on linkage and time
to linkage respectively. Participants who were lost to follow-
up were assumed not to have linked. Those who were
reported at the six month follow-up visit to have moved were
censored midway between enrolment and that visit. Those
who were in the study area but did not attend the six month
visit were censored at that visit. The primary analyses of the
intervention effect were adjusted for randomization stratum
as a fixed effect. Secondary analyses were adjusted for age
and sex a priori, and other characteristics that showed sub-
stantial baseline imbalance. Due to the nature of the interven-
tion (repeated counselling), it was expected that its effect
might change over time. Therefore, the proportional hazards
assumption was examined by splitting follow-up time into two
intervals (0–2 months and >two months) at a point corre-
sponding with the time of the second counselling session, and
testing for an interaction between trial arm and time. Similar
methods were used to estimate the effect of the intervention
on the proportions that adhered to CTXp, and on the time to
obtaining CD4 counts, and ART initiation among HIV-positive
participants, and on the proportion that accepted repeat HCT
among HIV-negative participants.
Analyses based on cluster-level summaries (Supplementary
File) were also performed to check the robustness of the indi-
vidual-level analysis, using methods for stratified cluster-ran-
domized trials [36]. Intervention effects on binary outcomes
were measured using prevalence ratios (PR), calculated as the
ratio of the arithmetic mean of the cluster-specific prevalence
of the outcome in each arm. The 95% confidence interval (CI)
was calculated with variance estimated from the residual
mean square from a two-way analysis of variance (ANOVA) of
cluster-specific prevalence on stratum and trial arm. Adjusted
PR were calculated as the arithmetic mean ratio of observed
to expected prevalences in each cluster, with logistic regres-
sion used to estimate the expected prevalence, adjusted for
age, sex, stratum and other variables that showed baseline
imbalance. CIs were obtained from an ANOVA of the
observed/expected prevalences on stratum and trial arm, as
described above. Intervention effects on time-to-event out-
comes were measured using rate ratios (RR) by similar meth-
ods; Poisson regression was used to estimate expected
number of events for the adjusted analyses.
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Data from the control arm were used to estimate k for link-
age to care. STATA version 12.0 (StataCorp, College Station,
TX, USA) was used for all analyses.
3 | RESULTS
The study was conducted between March 2015 and March
2016. 13,455 people (89.1% of those enumerated) were con-
tacted of which 12,100 (89.9%) accepted HBHCT (Figure 1).
Common reasons for declining HBHCTwere being HIV-positive
and already engaged in care (437, 32.3%), not wanting to know
one’s HIV status (397, 29.3%), and having recently undergone
HCT (214, 15.8%). Of those who accepted HBHCT, 551 (4.6%)
tested HIV-positive, of whom 205 (37.2%) were already in care
and thus ineligible. Of those eligible, 302 (87.3%) were enrolled,
of whom 265 (87.7%) were newly diagnosed with HIV. 110
HIV-negative individuals were also enrolled.
The median age of HIV-positive participants was 30.0 years
(interquartile range, 25.0–39.0; Table 1); the majority were
female (54.6%), married/cohabiting (60.3%), had incomplete
primary school/no formal education (60.3%) and had previ-
ously undergone HCT (80.5%). Baseline variables were gener-
ally balanced between trial arms; however, participants in the
intervention arm were more likely to report <30 min travel
time to the HIV clinic than those in the control arm (34.9%
vs. 22.2%). 25 (8.3%) HIV-positive participants were lost to
follow-up: 13 (4.3%) moved; 8 (2.6%) for unknown reasons; 2
(<1%) died; and 2 (<1%) withdrew. The distribution of baseline
characteristics among HIV-negative participants was similar to
that of HIV-positive participants (Table 1). 8 (7.3%) were lost
to follow-up.
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t 28 clusters
A
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n
Intervention arm: 14 clusters
Enumerated adults: 7928
Contacted: 7152
Accepted HBHCT: 6463
Tested HIV-positive: 281 
• Engaged in care (ineligible): 107
• Eligible: 174 
• Enrolled: 149 
o Mean number enrolled per 
cluster: 10.6 
• Not enrolled: 25
o Not interested: 14
o Unavailable for follow-up: 4
o Denial of HIV status: 1 
o Missing reason: 6
Tested HIV-negative: 6182
• Enrolled: 52
o Mean number enrolled per 
cluster: 3.7
Control arm: 14 clusters
Enumerated adults: 7168
Contacted: 6303
Accepted HBHCT: 5637
Tested HIV-positive: 270  
Engaged in care (ineligible): 98 
• Eligible: 172 
• Enrolled: 153
o Mean number enrolled per 
cluster: 10.9
• Not enrolled: 19
o Not interested: 12
o Unavailable for follow-up: 1
o Unable to consent: 1 
o Enrolled in other HIV study: 1 
o Missing reason: 4
Tested HIV-negative: 5367 
• Enrolled: 58
o Mean number enrolled per 
cluster: 4.1
Fo
llo
w
-u
p
Clusters lost to follow-up: 0
HIV-positive participants lost to follow-
up: 12 (8.1%)
HIV-negative participants lost to follow-
up: 5 (9.6%) 
Clusters lost to follow-up: 0
HIV-positive participants lost to follow-
up: 13 (8.5%)
HIV-negative participants lost to follow-
up: 3 (5.2%)
A
na
ly
si
s Clusters analysed: 14
HIV-positive participants analysed: 153
HIV-negative participants analysed: 58
Clusters analysed: 14
HIV-positive participants analysed: 149
HIV-negative participants analysed: 52
Figure 1. Flow of clusters and participants through the trial.
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3.1 | Linkage to care
134/302 participants (44.4%) reported to have linked to care
but clinic records were found for 127 (42.1%) only. Seven partici-
pants whose clinic records could not be found were re-inter-
viewed; all admitted that they had not linked. Of those confirmed
to have linked, 8 (6.3%) had registered with a facility outside of
the study area. Linkage to care was higher in the intervention
arm compared to the control arm [51.0% versus 33.3%; odds
ratio (OR) = 2.18, 95% CI = 1.26–3.78; Table 2]. The effect of
the intervention was similar after adjusting for age, sex and travel
time to the clinic [adjusted (aOR = 2.14, 95% CI = 1.24–3.7)].
The crude and adjusted effect estimates from the cluster-level
analysis were consistent with a higher linkage in the intervention
versus the control arm [prevalence ratio (PR) = 1.59, 95%
C = 1.09–2.33; aPR = 1.58, 95% CI = 1.07–2.34].
The probability of linkage was similar in both trial arms up to
the first month of follow-up. Subsequently, more participants
Table 1. Baseline characteristics of participants
HIV-positive participants HIV-negative participants
Intervention Control Intervention Control
N (%) N (%) N (%) N (%)
Total enrolled 149 153 52 58
Sex
Female 76 (51.0) 89 (58.2) 26 (50.0) 37 (63.8)
Male 73 (49.0) 64 (41.8) 26 (50.0) 21 (36.2)
Median age in years (IQR) 30.0 (25.0–38.0) 30.0 (25.0–40.0) 35.0 (25.0–44.5) 31.5 (23.0–42.0)
Age group
18–24 years 34 (22.8) 37 (24.2) 10 (19.2) 16 (27.6)
25–34 years 63 (42.3) 58 (37.9) 15 (28.9) 18 (31.0)
35–44 years 29 (19.5) 30 (19.6) 14 (26.9) 13 (22.4)
45+ years 23 (15.4) 28 (18.3) 13 (25.0) 11 (19.0)
Marital status
Married/cohabiting 85 (57.1) 97 (63.4) 38 (73.1) 43 (74.1)
Single 22 (14.8) 26 (17.0) 6 (11.5) 10 (17.2)
Divorced/separated/widowed 42 (28.2) 30 (19.6) 8 (15.4) 5 (8.6)
Education
None/incomplete primary 86 (57.7) 96 (62.8) 22 (42.3) 25 (43.1)
Primary 34 (22.8) 32 (20.9) 9 (17.3) 14 (24.1)
Above primary 29 (19.5) 25 (16.3) 21 (40.4) 19 (32.8)
Occupation
Subsistence farmer 84 (56.4) 80 (52.3) 16 (30.8) 25 (43.1)
Other 65 (43.6) 73 (47.7) 36 (69.2) 33 (56.9)
Socio-economic statusa
Low 56 (37.6) 61 (39.9) 10 (19.2) 19 (32.8)
Middle 52 (34.9) 56 (36.6) 18 (34.6) 14 (24.1)
High 41 (27.5) 36 (23.5) 24 (46.2) 25 (43.1)
Travel time to nearest HIV clinic
<30 minutes 52 (34.9) 34 (22.2) 21 (40.4) 12 (20.7)
30 minutes or more 97 (65.1) 119 (77.8) 31 (59.6) 46 (79.3)
Ever tested for HIV
No 30 (20.1) 29 (19.0) 1 (1.9) 1 (1.7)
Yes 119 (79.9) 124 (81.0) 51 (98.1) 57 (98.3)
Tested for HIV in the last 12 months
No 71 (47.7) 81 (52.9) 6 (11.5) 5 (8.6)
Yes 78 (52.4) 72 (47.1) 46 (88.5) 53 (91.4)
Previously aware of HIV-positive status
No 131 (87.9) 134 (87.6) – –
Yes 18 (12.1) 19 (12.4) – –
IQR, interquartile range.
a
Socio-economic status categories were obtained from a wealth index scale based on ownership of household and other properties using principal
component analysis.
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linked in the intervention arm than in the control arm with the
difference becoming more marked around the second month of
follow-up (Figure 2). The overall hazard ratio (HR) was 1.65
(95% CI = 1.11–2.44) and was similar after adjusting for age,
sex and travel time to the HIV clinic [adjusted hazard ratio
(aHR) = 1.62, 95% CI = 1.12 to 2.33; Table 3]. There was
strong evidence of interaction between trial arm and follow-up
time (p = 0.009). In the first interval (0–2 months), 57 (38.3%)
participants linked in the intervention arm versus 46 (30.1%) in
the control arm [HR = 1.32, 95% CI = 0.86–2.03; aHR = 1.30,
95% CI = 0.87–1.94]. In the second interval (>two months), 19
(20.7%) participants linked in the intervention arm versus 5
(4.7%) in the control arm [HR = 4.87, 95% CI = 1.79–13.27;
aHR = 4.78, 95% CI = 1.77–12.89]. The cluster-level analysis
was also consistent with an intervention effect on rate of link-
age [rate ratio (RR) = 1.84, 95% CI = 0.99–3.42; aRR = 1.92,
95% CI = 0.96–3.86)].
3.2 | Obtaining CD4 counts
One hundred and seven (35.4%) participants obtained CD4
counts; 67 (45.0%) in the intervention arm versus 40 (26.1%)
in the control arm. The overall HR was 1.91 (95% CI = 1.25–
2.93; Table 3) and was similar after adjusting for age, sex and
travel time to the HIV clinic [aHR = 1.86, 95% CI = 1.23–
2.80]. There was some evidence of interaction between trial
arm and follow-up time (p = 0.05). In the first follow-up
interval, 40 (26.8%) participants obtained CD4 counts in the
intervention arm versus 30 (19.6%) in the control arm
[HR = 1.45, 95% CI = 0.88–2.40; aHR = 1.41, 95% CI =
0.87–2.28]. In the second follow-up interval, 27 (24.8%) par-
ticipants obtained CD4 counts in the intervention arm versus
10 (8.1%) in the control arm [HR = 3.35, 95% CI = 1.59–
7.04; aHR=3.27, 95% CI = 1.57–6.81]. Results from the clus-
ter-level analysis were consistent with an intervention effect
on time to obtaining CD4 counts [RR = 2.10, 95% CI = 1.14–
3.84; aRR = 2.12, 95% CI = 1.22–3.70].
3.3 | ART initiation
Of those enrolled, 90 (29.8% of all participants and 70.9% of
those who linked) individuals initiated ART. This included 61
(95.3%) of 64 individuals who had a CD4 count of ≤500 cells/
mm3, the ART eligibility threshold at the time of the study
[12]. Overall, 50 (33.6%) participants initiated ART in the
intervention arm versus 40 (26.1%) in the control arm
[HR = 1.31 (95% CI = 0.85–2.04)]. The effect estimate was
unchanged after adjusting for age, sex and travel time to the
HIV clinic [aHR = 1.33, 95% CI = 0.85–2.06; Table 3]. There
was strong evidence of interaction between trial arm and fol-
low-up time (p = 0.0007). In the first follow-up interval, 25
(16.8%) participants initiated ART in the intervention arm ver-
sus 33 (21.6%) in the control arm (HR = 0.78, 95%
CI = 0.46–1.34; aHR = 0.79, 95% CI = 0.46–1.34). In the
Table 2. Effect of follow-up counselling on linkage to care, adherence to cotrimoxazole prophylaxis (CTXp) and uptake of repeat
HCT
Intervention arm Control arm OR (95% CI) p-value aOR (95% CI)a p-value
Among HIV-positive participants
Linkage to care 76/149 (51.0) 51/153 (33.3) 2.18 (1.26–3.78) 0.008 2.14 (1.24–3.70) 0.009
Adherence to CTXp 66/149 (44.3) 43/153 (28.1) 2.15 (1.16–3.98) 0.02 2.17 (1.20–3.93) 0.01
Among HIV-negative participants
Uptake of repeat HIV test 42/52 (80.8) 46/58 (79.3) 1.08 (0.42–2.78) 0.87 0.70 (0.24–2.03) 0.52
OR, odds ratio; aOR, adjusted odds ratio; CI, confidence interval.
a
Adjusted for age, sex, strata and travel time to the nearest HIV clinic.
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Linkage to care after HBHCT
Figure 2. Kaplan–Meier estimates of linkage to care.
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second follow-up interval, 25 (20.2%) participants initiated
ART in the intervention arm versus 7 (5.8%) in the control
arm (HR = 3.90, 95% CI = 1.67–9.11; aHR = 3.96, 95%
CI = 1.69–9.26). In the cluster-level analysis, the intervention
also increased ART initiation overall, but there was no evi-
dence of a significant difference (RR = 1.21, 95% CI = 0.69–
2.13; aRR = 1.27, 95% CI = 0.77–2.12).
3.4 | Adherence to CTXp
36.1% of the participants reported adhering to CTXp; adher-
ence was higher in the intervention arm compared to the con-
trol arm [44.3% versus 28.1%; OR = 2.15, 95% CI = 1.16–
3.98; adjusted odds ratio (aOR) (adjusted for age, sex and
time to the HIV clinic) = 2.17, 95% CI = 1.20–3.93; Table 2].
The cluster-level estimates for the effect of intervention on
adherence to CTXp were also consistent with significantly
higher adherence in the intervention arm compared to the
control arm (PR = 1.69 95% CI = 1.04–2.75; aPR = 1.70,
95% CI = 1.06–2.74).
3.5 | Uptake of repeat HCT among HIV-negative
participants
Overall uptake of repeat HCT was 80.0%. There was no evi-
dence of a difference in uptake between intervention and con-
trol arms [80.8% versus 79.3%; OR = 1.08, 95% CI = 0.42–
2.78; aOR (adjusted for age, sex and time to the HIV
clinic) = 0.70, 95% CI = 0.24–2.03; Table 2]. Conclusions from
the cluster-level analysis were similar (PR = 0.95, 95%
CI = 0.76–1.20; aPR = 0.90, 95% CI = 0.72–1.13).
3.6 | Contamination
Two (<1%) individuals reported that they had discussed the
trial with participants from villages other than their own.
3.7 | Coefficient of variation
k values for linkage to care and rate of linkage were 0.33 and
0.52 respectively.
4 | DISCUSSION
This trial showed that an intervention comprising two brief
counselling sessions for adults identified with HIV through
HBHCT strongly increases linkage to care. In the individual-
level analysis, the intervention was associated with a twofold
increase in the proportion of persons linking to care, and
approximately 5-fold increase in the hazard of linkage after
the second counselling visit; the estimates did not change
after adjusting for age, sex and travel time to the clinic.
Results from the cluster-level analysis were also consistent
with an intervention effect on linkage to care and time to link-
age. The trial also showed that counselling significantly
increased the rate of obtaining CD4 counts and ART initiation,
and adherence to CTXp. For all time-to-event outcomes, the
intervention effect increased with time, and became apparent
after the second counselling visit. Although the two coun-
selling sessions covered similar content, the second session
also provided an opportunity to follow-up on issues identified
in the first session as well as address new concerns.
The effect estimates observed in our trial were stronger
than those observed in the only other trial that previously
investigated the impact of counselling on linkage to care
among HIV-positive persons identified through community-
based HCT (mobile HCT and HBHCT) in SSA [37].
Counselling in that trial increased the proportion of individuals
linking to care by 4% only. This was probably due to the
already high (89%) level of linkage to care in the standard-of-
care (referral only) arm of that trial. In contrast, linkage to
care in our standard-of-care arm was 33%, a figure consistent
Table 3. Effect of follow-up counselling on time to linkage to care, obtaining CD4 counts and antiretroviral therapy (ART) initiation
Intervention arm Control arm
HR (95% CI) p-value aHR (95% CI)a p-valueN n pm N n pm
Linkage to careb
Entire follow-up period 149 76 492 153 51 590 1.65 (1.11–2.44) 0.02 1.62 (1.12–2.33) 0.02
0–2 months 149 57 224 153 46 239 1.32 (0.86–2.03) 0.20 1.30 (0.87–1.94) 0.20
>2 months 92 19 268 107 5 351 4.87 (1.79–13.27) 0.002 4.78 (1.77–12.89) 0.002
Obtaining CD4 countsb
Entire follow-up period 149 67 561 153 40 664 1.91 (1.25–2.93) 0.005 1.86 (1.23–2.80) 0.007
0–2 months 149 40 247 153 30 266 1.45 (0.88–2.40) 0.14 1.41 (0.87–2.28) 0.17
>2 months 109 27 313 123 10 398 3.35 (1.59–7.04) 0.001 3.27 (1.57–6.81) 0.002
ART initiationb
Entire follow-up period 149 50 630 153 40 662 1.31 (0.85–2.04) 0.22 1.33 (0.85–2.06) 0.21
0–2 months 149 25 264 153 33 262 0.78 (0.46–1.34) 0.37 0.79 (0.46–1.34) 0.38
>2 months 124 25 365 120 7 399 3.90 (1.67–9.11) 0.002 3.96 (1.69–9.26) 0.002
N, sample size; n, number with outcome; pm, person-months; HR, hazard ratio; aHR, adjusted hazard ratio; CI, confidence interval.
a
Adjusted for age, sex, strata and travel time to nearest HIV clinic.
b
The respective p-values for interaction between trial arm and follow-up time for linkage to care, obtaining CD4 counts and ART initiation were
0.009, 0.05 and 0.0007.
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with that observed after routine referral in previous studies
[20,30,31,38–40].
Linkage to care did not differ between trial arms in the
month between HIV diagnosis and the first counselling ses-
sion, suggesting that on its own, knowledge of trial arm had
no effect on linkage. The probability of linking to care was also
higher in the first month than in subsequent periods. This has
been observed previously [10,38] and may mean that persons
who accept their status, and are motivated to get help,
promptly link to care following HIV diagnosis [41]. The finding
also suggests that one month after HIV diagnosis may be the
optimal time for targeting persons who are less motivated to
seek care.
Whilst the overall proportion of participants who initiated
ART was low, ART initiation among those who linked was high.
This suggests that linkage to care is the main bottleneck to
uptake of ART in this population. As the new WHO guidelines
recommending ART initiation regardless of CD4 count
become widely adopted, the focus of linkage efforts is likely to
shift from just registering for care to ART initiation [42]. Even
so, in the absence of home-based ART initiation, HIV-positive
patients identified through HBHCT will still have to visit and
register with an HIV clinic before receiving ART.
Although linkage to care was significantly higher in the
intervention arm, it was still low [25]. This finding points to
the existence of additional barriers that cannot be addressed
by counselling and the need to identify and evaluate interven-
tions that target these barriers. Such barriers may be pro-
grammatic; socio-cultural or structural [24]. Since no single
intervention is likely to address all linkage barriers, research
will also be required to identify how best to combine interven-
tions that are found to be effective. Higher linkage rates than
ours have been observed in some studies that used coun-
selling to facilitate linkage to care [43]. However, most of
these studies were prone to confounding, used counselling
alongside other interventions [6,7,9], or were conducted in
settings where linkage was high even in the absence of any
intervention [37].
Consistent with previous studies in similar settings [42,44],
uptake of repeat HCT among HIV-negative individuals was
high. Previous HCT may reduce the psychological stress asso-
ciated with testing hence making it easier to accept repeat
HCT. Counselling had no measurable effect on uptake of
repeat HCT. This may partly be due to the high (79%) uptake
of HCT in the control arm, and partly due to the small sample
size.
Despite the strong overall intervention effect, outcomes
varied substantially between clusters with some intervention
clusters showing poorer outcomes than control clusters
(Supplementary File). This may have been due to chance or
interaction between the intervention and key cluster-level
characteristics such as access to health facilities. Variations in
implementation of the intervention are unlikely to have
affected response to intervention since the same counsellors
worked across all clusters.
The study had a number of strengths. It is the first ran-
domized trial to demonstrate that counselling provided after
referral substantially increases linkage to care among HIV-
positive persons identified through HBHCT in SSA. The trial
was conducted under real-world conditions in a relatively
large geographical area with facilities that provided standard
services. Participation and retention rates were high and did
not differ by treatment arm thereby reducing risk of selec-
tion bias. The cluster-randomized design further minimized
selection bias, and ensured that the risk of contamination
between treatment arms, and consequently that of diluting
intervention effects, was low. Referrals were tracked to verify
outcomes for all participants who reported having linked to
care. This minimized the risk of bias that would have resulted
from reliance on self-reported data or incomplete tracking of
referrals.
The study also had some limitations. First, it was an open-
label study: knowledge of the interventions may have influ-
enced participants’ decisions to remain in the study. However,
since there was no differential loss to follow-up between
arms, this is unlikely to have been a major issue. Second,
whereas registering for care is a critical step in the HIV care
cascade [27,45], it may not result in sustained engagement in
care [46]. Therefore, more research may be necessary to
demonstrate the effectiveness of counselling on retention in
care and other long-term care outcomes. Third, the coun-
selling sessions and collection of outcome data were con-
ducted by the same person for some participants. This may
have increased the risk of reporting bias. In general, reporting
bias is unlikely to have been a major issue since only data on
adherence to CTXp were based on self-reports. Fourth, the
observed k was higher than that assumed for the sample size
estimation implying that the trial could potentially have been
underpowered.
5 | CONCLUSIONS
The results of this trial suggest that counselling strongly
increases linkage to care and uptake of other services includ-
ing ART among HIV-positive adults identified through HBHCT.
In settings such as ours, counselling may enhance efforts
aimed at achieving the second UNAIDS target (i.e. receipt of
ART for 90% of the people who know their HIV status) [47]
and should be considered for scaling up.
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